Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Tomography, X-Ray Computed × 90 days × Clear all

Sponsor

Conditions

Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Anus Neoplasms 2 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Disease 1 Digestive System Diseases 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma in Situ 1

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Cholecalciferol 1 Azacitidine 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡